Gotistobart for Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This LTE study will examine the long-term overall survival and safety of gotistobart in patients with advanced solid tumors.
Are You a Good Fit for This Trial?
This trial is for adults (18+) with advanced solid tumors who have already been treated with gotistobart in earlier related studies and are either still receiving treatment or being followed up after treatment.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Gotistobart
Trial Overview
The study is looking at the long-term safety and survival of people taking gotistobart, a drug used to treat advanced solid tumors. Only those previously enrolled in specific parent trials can join.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants enrolling in Cohort B are those who, upon rolling over into this LTE study, are determined to derive clinical benefit from continued study treatment. These participants will continue to receive the study treatment specified in the parent trial, with gotistobart or an gotistobart-based combination, until one of the following occurs.
Participants enrolling in Cohort A of the trial are those who, upon rolling over into this LTE study, are in the survival follow up period of the parent trial. Participants who discontinue study treatment in parent trial should be encouraged to roll over to this LTE for longer survival follow up through periodic clinical visits or telemedicine visits.
Find a Clinic Near You
Who Is Running the Clinical Trial?
OncoC4, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.